Interactive modules by Olga Goodman, MD.Copyright protected · Read termsClose terms

All RheumaView™ interactive modules, quizzes and educational cases are original works developed by Olga Goodman, MD.

Without the author’s prior written permission, you may not copy or republish these modules or their components; extract, reuse or modify their original software code (“engines”); or use that code to build your own modules, quizzes or other products.

You may not claim these works as your own or remove or replace the author’s name or copyright notices. When quoting material, credit Olga Goodman, MD, identify the source and include a direct link to the original.

Free or public access is provided for learning and does not grant permission to copy, adapt or redistribute the materials. Unauthorized use of protected material may constitute copyright infringement. Exceptions and limitations provided by applicable law remain unaffected.

Sharing direct links to the modules is welcome.

© 2026 Olga Goodman, MD. All rights reserved.

Spondyloarthritis family · A closer look at PsA

How psoriatic arthritis is diagnosed

What the examination, blood tests and images can establish — and why no single result tells the whole story.

Olga Goodman, MD · Sources checked 27 September 2026

Chapter 3 of 21

The essentials

PsA is a clinical diagnosis assembled from history, examination and selected investigations. There is no single confirmatory blood test. Normal inflammatory markers do not exclude disease, and psoriasis does not explain every joint symptom. The aim is to identify inflammation, consider alternatives and choose tests that answer a specific question.

Start with the clinical question

The clinician asks where and when symptoms began, whether there was swelling, what rest and movement do, and how function has changed. Examination may include joints, tendon attachments, swollen digits, movement of the spine, skin and nails. Previous psoriasis, family history, eye or bowel inflammation and treatments already used are relevant. 1, 2

A good explanation should identify the findings supporting PsA, the main alternatives and any uncertainty. Reassessment is reasonable when symptoms evolve; uncertainty does not mean that symptoms are imaginary.

Blood tests: purpose, contribution and limits

CRP and ESR help assess systemic inflammation and sometimes its course. Raised values are nonspecific; normal values cannot exclude spondyloarthritis. RF and anti-CCP are mainly used when considering rheumatoid arthritis. Negative results do not prove PsA, and positive results must be interpreted in the full clinical picture. 4

HLA-B27 may help assess a suspected axial pattern. It is a susceptibility marker, not a diagnosis: many carriers never develop disease, and a negative result does not rule it out. Blood counts, liver or kidney tests often assess general health, other causes of symptoms or treatment safety. Ask which task each test serves.

X-ray, ultrasound or MRI?

X-rays show structural changes and provide a baseline for comparison. Early inflammatory disease can be present before characteristic radiographic changes appear. Ultrasound can examine accessible joints, tendon sheaths and entheses; Doppler can add information about blood flow associated with inflammation. MRI can assess inflammation and structure in selected deep regions, including the sacroiliac area. 1, 4

No scan establishes PsA in isolation. Loading, degeneration and other conditions can produce findings that overlap with inflammation. The requested region and protocol should fit the question. Bring prior images as well as reports when available; comparison may be more useful than repeating a study without a clear purpose.

Screening, classification and diagnosis are different

Screening tools such as PEST help identify people with psoriasis who may need rheumatology assessment. NICE recommends periodic assessment, including annually for people with psoriasis; new concerning symptoms should be assessed without waiting for that review. PEST does not detect axial arthritis or inflammatory back pain. A low screening result should not dismiss those symptoms. 3

CASPAR is a classification framework developed for research. It first requires inflammatory disease of joints, spine or entheses; its point system is not a stand-alone self-diagnostic test. A clinician must establish what the findings mean. This chapter links to the original framework and guidance rather than reproducing a questionnaire or offering an unvalidated translated score. 5

What else might explain the symptoms?

Osteoarthritis, rheumatoid arthritis, gout or other crystal arthritis, infection, tendon overload and pain amplification can resemble parts of PsA. Several conditions can coexist. An established PsA diagnosis does not make every new pain a flare.

With an acutely swollen joint, fluid sampling may be needed to look for crystals and infection. Fever can be absent, especially with immune-modifying treatment. A rapidly worsening hot joint or marked illness needs urgent assessment rather than a trial of leftover steroids.

Bring a short timeline, not just a test folder

Prepare onset dates, affected areas, episodes of visible swelling and morning limitations. Add dated photographs, prior imaging and reports, medication names and doses, benefits, adverse effects and treatment interruptions. Note skin, nail, eye and bowel symptoms, even if they seem unrelated.

Choose two or three questions you most want answered. The existing Visit Planner can organise this information; it does not calculate the probability of PsA or replace the examination.

Detective work: how PsA is diagnosed — Free after registration →

Go deeper

When symptoms and results seem to disagree

A normal result is reassuring only for the question it can answer. A normal CRP does not exclude local inflammation; an old erosion does not by itself prove current activity. The clinician may review the timing, examine another symptomatic area or choose a different method.

Ask what finding would change the working diagnosis or treatment. Repeating broad test panels without a question can add confusing incidental results. A follow-up plan should state what is being watched, when to return and what warrants earlier review. 1, 4

Questions for your visit

  1. What findings support PsA in my case?
  2. What other explanations remain possible?
  3. What will this test change, and what can it not exclude?
  4. If the results are inconclusive, what is our follow-up plan?

When to seek urgent help

A painful red eye, light sensitivity or a sudden change in vision needs urgent assessment. A newly hot, swollen joint, especially with fever or feeling unwell, also needs prompt assessment.

Sources & evidence notes

Sources checked 27 September 2026

  1. NIAMS. Psoriatic arthritis: overview, diagnosis and care (2024).
  2. Coates LC et al. GRAPPA recommendations 2021. Nature Reviews Rheumatology (2022).
  3. NICE CG153. Psoriasis: assessment and management. Sections 1.2.2.1–1.2.2.3.
  4. NICE NG65. Spondyloarthritis: diagnosis and management. Recognition, referral and diagnosis.
  5. Taylor W et al. CASPAR classification criteria. Arthritis & Rheumatism (2006).
  6. Gossec L et al. EULAR recommendations: 2023 update. Annals of the Rheumatic Diseases (2024).

Educational information for patients and caregivers. This personal publication is not the clinic portal and does not provide individual diagnosis or treatment. Discuss medication changes with your own care team.

© 2026 Olga Goodman, MD · A RheumaView publication. Copying without attribution prohibited.

Share this page

FacebookLinkedInXWhatsAppTelegram

Topics: PsoriasisPsoriatic arthritisSpondyloarthritis